Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine
- PMID: 29259600
- PMCID: PMC5723287
- DOI: 10.3389/fmicb.2017.02412
Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine
Abstract
Human rhinovirus (HRV) remains a leading cause of several human diseases including the common cold. Despite considerable research over the last 60 years, development of an effective vaccine to HRV has been viewed by many as unfeasible due, in part, to the antigenic diversity of circulating HRVs in nature. Over 150 antigenically distinct types of HRV are currently known which span three species: HRV A, HRV B, and HRV C. Early attempts to develop a rhinovirus vaccine have shown that inactivated HRV is capable of serving as a strong immunogen and inducing neutralizing antibodies. Yet, limitations to virus preparation and recovery, continued identification of antigenic variants of HRV, and logistical challenges pertaining to preparing a polyvalent preparation of the magnitude required for true efficacy against circulating rhinoviruses continue to prove a daunting challenge. In this review, we describe HRV biology, antigenic diversity, and past and present advances in HRV vaccine design.
Keywords: common cold; respiratory disease; rhinovirus; vaccine; viral diversity.
Figures

Similar articles
-
A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques.Nat Commun. 2016 Sep 22;7:12838. doi: 10.1038/ncomms12838. Nat Commun. 2016. PMID: 27653379 Free PMC article.
-
Challenges in developing a cross-serotype rhinovirus vaccine.Curr Opin Virol. 2015 Apr;11:83-8. doi: 10.1016/j.coviro.2015.03.004. Epub 2015 Mar 29. Curr Opin Virol. 2015. PMID: 25829255 Review.
-
Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection.Front Microbiol. 2017 Aug 31;8:1646. doi: 10.3389/fmicb.2017.01646. eCollection 2017. Front Microbiol. 2017. PMID: 28912760 Free PMC article.
-
Genome-wide diversity and selective pressure in the human rhinovirus.Virol J. 2007 May 3;4:40. doi: 10.1186/1743-422X-4-40. Virol J. 2007. PMID: 17477878 Free PMC article.
-
From sneeze to wheeze: what we know about rhinovirus Cs.J Clin Virol. 2013 Aug;57(4):291-9. doi: 10.1016/j.jcv.2013.04.015. Epub 2013 May 25. J Clin Virol. 2013. PMID: 23714395 Review.
Cited by
-
Rhinovirus-induced Rapidly Progressing Acute Respiratory Distress Syndrome in an Immunocompetent Host.Cureus. 2019 Feb 1;11(2):e3997. doi: 10.7759/cureus.3997. Cureus. 2019. PMID: 30989006 Free PMC article.
-
Childhood Origins of Adult Lung Disease as Opportunities for Prevention.J Allergy Clin Immunol Pract. 2020 Mar;8(3):849-858. doi: 10.1016/j.jaip.2020.01.015. J Allergy Clin Immunol Pract. 2020. PMID: 32147138 Free PMC article.
-
Enterovirus virus-like-particle and inactivated poliovirus vaccines do not elicit substantive cross-reactive antibody responses.PLoS Pathog. 2024 Apr 25;20(4):e1012159. doi: 10.1371/journal.ppat.1012159. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38662650 Free PMC article.
-
Clinical Significance of Rhinoviruses and Progress Toward Vaccination.Allergy Asthma Immunol Res. 2025 Jul;17(4):414-432. doi: 10.4168/aair.2025.17.4.414. Allergy Asthma Immunol Res. 2025. PMID: 40736772 Free PMC article. Review.
-
An investigation of rhinovirus infection on cellular uptake of poly (glycerol-adipate) nanoparticles.Int J Pharm. 2020 Nov 15;589:119826. doi: 10.1016/j.ijpharm.2020.119826. Epub 2020 Aug 29. Int J Pharm. 2020. PMID: 32871219 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous